Literature DB >> 23611830

Pre-exposure of Candida species to cytarabine and daunorubicin does not affect their in vitro antifungal susceptibility and virulence in flies.

Régis A Zanette, Dimitrios P Kontoyiannis.   

Abstract

Entities:  

Keywords:  Candida; Drosophila; cytarabine; daunorubicin; susceptibility; virulence

Mesh：

Substances：

Year:  2013        PMID： 23611830      PMCID： PMC3710338          DOI： 10.4161/viru.24387

Source DB:  PubMed          Journal:  Virulence        ISSN： 2150-5594            Impact factor:   5.882


× No keyword cloud information.
  11 in total

1.  Doxorubicin induces drug efflux pumps in Candida albicans.

Authors:  Grzegorz Kofla; Vincent Turner; Bettina Schulz; Ulrike Storch; Daniela Froelich; Bénédicte Rognon; Alix T Coste; Dominique Sanglard; Markus Ruhnke
Journal:  Med Mycol       Date:  2010-09-06       Impact factor: 4.076

2.  Clinical infections and bloodstream isolates associated with fever in patients undergoing chemotherapy for acute myeloid leukemia.

Authors:  T A Madani
Journal:  Infection       Date:  2000 Nov-Dec       Impact factor: 3.553

3.  Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistance.

Authors:  Ronen Ben-Ami; Guillermo Garcia-Effron; Russell E Lewis; Soledad Gamarra; Konstantinos Leventakos; David S Perlin; Dimitrios P Kontoyiannis
Journal:  J Infect Dis       Date:  2011-08-15       Impact factor: 5.226

4.  Assessing signaling pathways associated with in vitro resistance to cytotoxic agents in AML.

Authors:  David B Rosen; James A Cordeiro; Aileen Cohen; Norman Lacayo; Donna Hogge; Rachael E Hawtin; Alessandra Cesano
Journal:  Leuk Res       Date:  2012-04-21       Impact factor: 3.156

5.  In vitro susceptibilities of sucrose-negative Candida tropicalis, Candida lusitaniae, and Candida norvegensis to amphotericin B, 5-fluorocytosine, miconazole, and ketoconazole.

Authors:  D G Ahearn; M S McGlohn
Journal:  J Clin Microbiol       Date:  1984-03       Impact factor: 5.948

6.  A historical perspective on the development of the cytarabine (7days) and daunorubicin (3days) treatment regimen for acute myelogenous leukemia: 2013 the 40th anniversary of 7+3.

Authors:  Marshall A Lichtman
Journal:  Blood Cells Mol Dis       Date:  2012-11-12       Impact factor: 3.039

7.  Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies.

Authors:  Guillermo Garcia-Effron; Dimitrios P Kontoyiannis; Russell E Lewis; David S Perlin
Journal:  Antimicrob Agents Chemother       Date:  2008-09-15       Impact factor: 5.191

8.  Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species.

Authors:  Georgios Chamilos; Michail S Lionakis; Russell E Lewis; Jose L Lopez-Ribot; Stephen P Saville; Nathaniel D Albert; Georg Halder; Dimitrios P Kontoyiannis
Journal:  J Infect Dis       Date:  2006-02-28       Impact factor: 5.226

9.  Catalase activity in Candida albicans exposed to antineoplastic drugs.

Authors:  Carlos E B Linares; Deizi Griebeler; Denise Cargnelutti; Sydney H Alves; Vera M Morsch; Maria R C Schetinger
Journal:  J Med Microbiol       Date:  2006-03       Impact factor: 2.472

Review 10.  The potential impact of antifungal drug resistance mechanisms on the host immune response to Candida.

Authors:  Russell E Lewis; Pierluigi Viale; Dimitrios P Kontoyiannis
Journal:  Virulence       Date:  2012-06-22       Impact factor: 5.882
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.